Less than 50% of people in #Africa have access to the healthcare services they need, with women, girls, as well as other vulnerable groups such as people with disabilities or from LGBTQ+ communities, facing even greater disparities. ➡️For 20 years, African countries have strived toward Universal Health Coverage (#UHC). In 2001, African Union (AU) countries pledged to allocate 15% of their budgets to #health. Yet, only 37% have a formal UHC commitment. Investing in UHC can have a high upfront cost, but it is vital for economic growth. It's an investment in healthier and stronger economies. 📚Read more on how we can forge a shared path toward UHC in Africa in a blog by Karim Bendhaou, Africa Engagement Committee Chair, IFPMA and Head of Africa Bureau, Merck Group: https://lnkd.in/ezdsQnqC
L'accès aux examens sanguins, à l'imagerie puis à une prise en charge reste à ce jour une problématique majeure de la santé publique en Afrique ....a contrario grand producteur de matière première..
Great to hear your voice
Thanks for sharing Karim Bendhaou
Bien dit !
Executive Board Advisor & Consultant. International scaleup. Go-to-market options. Optimising international scaleup through distributors. Improving business development success in complex sales for B2B service providers.
2moIFPMA This is a futile exercise. The onus is on governments who are not in the least bit interested. They want free handouts, donations and support from R&D pharma companies. Such expectations are both unrealistic and unsustainable. Big Pharma are wasting their money in these endeavours. Many are under an illusion that their efforts will make a difference. It won't! It is a waste of money - they just dont know it - YET!